CLASS II Device recall · Reported 21 Mar 2018 · FDA Enforcement Report

Neoplastine¿ Cl Plus @ recalled by Diagnostica Stago

Diagnostica Stago is recalling Neoplastine¿ Cl Plus @ (, distributed nationwide in the US. The recall was initiated on 25 Oct 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot 115080 (Exp: 01-2018) Lot 251241 (Exp: 01-2018)
Quantity recalled1636 Kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1066-2018
FDA event ID
79292
Recalling firm
Diagnostica Stago, Parsippany, NJ
Classification
Class II
Status
Terminated
Recall initiated
25 Oct 2017
FDA classified
15 Mar 2018
Reported
21 Mar 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

25 Oct 2017Recall initiated by company
15 Mar 2018Classified by FDA+141 days
21 Mar 2018Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%).

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Neoplastine¿ Cl Plus @ (ref.00374) Product Usage: Manual or automated determination of the prothrombin time (PT).

Where it was distributed

Nationally

Nationwide

Questions about this recall

Why was it recalled?

Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%).

Which lots are affected?

Lot 115080 (Exp: 01-2018) Lot 251241 (Exp: 01-2018)

Where was it sold?

Nationally

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 79292

This product is part of a recall event; the main page for the event is STA - Neoplastine¿ Cl Plus ¿ recalled by Diagnostica Stago.

More recalls from Diagnostica Stago

All 27

Other Other Medical Devices recalls

All 13,778